Amgen currently leases space across the BOP campus in seven buildings, some of which is subleased by Amgen to third parties. The amendment provides Amgen the ability to continue its occupancy at three of its currently leased buildings through 2029, while at the same time providing Amgen flexibility to terminate its occupancy in these buildings at earlier dates subject to advance notice requirements.
Summary of Amgen Amendment Lease Terms
1100, 1120 &
(1) Healthpeak has the right to terminate 81,250 square feet in
(2) Amgen has the right to terminate 68,000 square feet in 2022 and 189,000 square feet in 2024.
"We look forward to continuing our longstanding relationship in
This press release contains forward-looking statements within the meaning of federal securities laws and regulations. These forward-looking statements are identified by their use of terms and phrases such as "believe," "expect," "intend," "will," "project," "anticipate," "position," and other similar terms and phrases, including references to assumptions and forecasts of future results. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those anticipated at the time the forward-looking statements are made. These risks include but are not limited to the risk that Amgen will exercise its rights to terminate lease space, that we will be unable to timely find a replacement tenant or tenants on similar terms, and those risks and uncertainties associated with Healthpeak's business described in its Annual Report on Form 10-K for the fiscal year ended
Senior Director – Investor Relations
View original content to download multimedia:http://www.prnewswire.com/news-releases/healthpeak-announces-lease-amendment-and-extension-with-amgen-in-south-san-francisco-300971644.html